Scott Global: Genetic-Test Orders Disguised as Hourly Marketing

The Scott Global telemedicine fraud case exposed a call-center business that bought doctors’ orders for cancer-screening genetic tests, sold tests and orders to laboratories, and disguised referral payments as hourly marketing. The Justice Department’s account of the owner’s criminal trial describes a business in which beneficiaries heard that Medicare covered the test, doctors supplied orders without treating them, and laboratories paid for the referrals. The invoices described hours. The business earned its money from tests.

Scott Global operated a telemarketing call center in Orlando. According to the trial evidence described by the Justice Department, its owner targeted Medicare beneficiaries with false coverage pitches for tests costing as much as $6,000 each. After a beneficiary agreed, the owner paid telemedicine companies for the doctor’s order that allowed the test to move toward laboratory billing.

How the Genetic-Test Order Chain Worked

Scott Global controlled recruitment and arranged the orders, while laboratories performed the tests and billed Medicare. The Eleventh Circuit’s account of the criminal trial evidence follows the transaction through the businesses between those endpoints.

Scott Global employees bought Medicare-beneficiary lists from a data broker. Using scripts supplied by eLab Partners, telemarketers called the people on those lists, collected biographical information and medical histories, and obtained the names of their primary-care physicians. Scott Global arranged shipment of testing kits and its owner paid MedSymphony, a telemedicine company, for doctors’ orders authorizing the tests.

The specimens traveled back through the marketing business. Beneficiaries returned them to a post-office box controlled by Scott Global. eLab Partners, the broker, collected the specimens and sent them with the doctors’ orders to one of three laboratories. The laboratories performed the tests and posted results on MedSymphony’s portal. When Medicare paid, the laboratories shared the reimbursement proceeds with the call-center owner and other participants.

The remote doctor’s product was an order another business could bill against. Looking only for a billed telemedicine visit can miss the business built around selling those orders.

The Doctor’s Name Was Collected, Then Bypassed

The criminal trial evidence showed that Scott Global obtained beneficiaries’ primary-care physician information but arranged testing orders through MedSymphony instead of contacting those physicians. The doctors who supplied the orders had no prior relationship with the beneficiaries, rarely communicated directly with them, never examined them before ordering the tests, and never provided them medical treatment.

MedSymphony approved 98% of Scott Global’s requests. A nearly automatic approval process supplied the signatures the call center needed to keep tests moving.

The court explained that CGx testing used DNA sequencing to identify mutations associated with future cancer risk. The tests did not determine whether a beneficiary already had cancer. It also explained the Medicare diagnostic-test requirement relevant to the case: the ordering physician treats the beneficiary for a specific medical problem and uses the results to manage that problem. The missing relationship concerned both the decision to order the test and what happened after the result arrived.

A Cancer History That Changed Inside the Form

One beneficiary’s test order contained the contradiction on its face. In the court’s description of that order, the form reported no personal cancer history and left the symptoms field blank. Yet the doctor wrote that the beneficiary was “concerned about cancer based on his history of cancer” and recommended testing based on family history and documented symptoms.

The doctor never examined that beneficiary or discussed the results with him. A laboratory billed Medicare $12,601 for the test. Medicare received a bill backed by a cancer history the order form itself denied. For someone who sees intake records and signed orders in ordinary work, that is a much more concrete discrepancy than a general suspicion about telemedicine.

Hourly Marketing Invoices Hid Referral Payments

Scott Global’s owner submitted invoices that made per-referral payments look like payment for hourly marketing services. The Justice Department’s criminal-trial account says he sent those invoices to laboratories and other marketers to conceal kickbacks received in exchange for genetic tests and doctors’ orders.

The court’s account supplies the commercial explanation behind the invoices. eLab told the owner that Scott Global’s profits depended on the number of tests the laboratories accepted and successfully processed. That connects the payment to the laboratory’s output. A timesheet tells a story about labor. An arrangement that pays according to accepted tests tells a story about referrals.

The owner also acknowledged the payment problem in phone calls introduced at trial. The court quoted him discussing payments to telemedicine doctors for signing the testing orders:

The owner knew he was paying for doctors’ signatures and that those payments were improper. The same disguise appeared in a separate case involving Ark Laboratory Network. In its September 2019 criminal charging announcement, the Justice Department alleged that Ark’s operators and other participants agreed to payments based on laboratories’ Medicare revenue, then issued sham invoices purporting to charge hourly rates. The amount had already been agreed upon before the invoice dressed it up as time. Scott Global’s case was also part of Operation Double Helix, the federal investigation focused on fraudulent genetic cancer testing.

The Laboratory Claims and the Marketer’s Cut

For November 2018 through May 2019, the Justice Department’s January 2021 trial announcement says laboratories submitted more than $2.8 million in claims for tests referred by the owner, Medicare paid over $880,000, and the owner personally received approximately $180,000. The scheme took Medicare’s money for tests the ordering doctors never used to treat the beneficiaries. For a laboratory billing employee or someone handling marketing invoices, the payment chain connects a claim in one system to a referral payment in another. The hourly description obscured why money traveled back to the business that recruited the beneficiary.

What Evidence Is Needed to Prove Fraud?

Evidence in an order-selling case connects what the beneficiary said, what the doctor certified, what the laboratory billed, and what triggered payment to the marketer. Scott Global’s criminal case shows why those connections matter: the primary-care information went unused, a signed order contradicted its own history fields, and compensation depended on tests the laboratories accepted.

Our work with an insider brings different views into one account of the transaction. A call-center employee may know the script and what the beneficiary actually said. Someone processing orders may see changes between the intake history and the doctor’s recommendation. A laboratory employee may see which specimens and orders were accepted, the resulting claims, and the Medicare payment records. The person handling marketing invoices may know how the amount was set before anyone entered an hourly description.

The 2024 Rutgers University Law Review analysis Plausible Cause: Connecting the FCA and AKS in the Context of Health Care Fraud examines the connection between kickback arrangements and the claims they produce. It points to OIG fraud alerts as useful descriptions of suspicious business arrangements and the claims those arrangements can generate. For this kind of case, the practical question is concrete: which testing orders and laboratory claims did the disguised referral payments buy?

What Is a Red Flag for Health Care Fraud?

In an order-producing telemedicine arrangement, recruitment around free or low-cost items, inadequate patient contact, compensation tied to orders, and missing follow-up are suspect features identified in OIG’s July 20, 2022 alert. In Scott Global’s case, the doctors rarely communicated with beneficiaries and never examined or treated them.

You Know What the Invoice Really Paid For

If you handled the calls, testing orders or payments behind a supposed hourly marketing arrangement, speak to our whistleblower experts about what the invoices really paid for. We build the case with you and bring in healthcare fraud whistleblower lawyers who understand laboratory referrals and telemedicine orders. We stay alongside you as your knowledge of the business becomes the evidence used to pursue a recovery. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.